Skip to main content

news

News
05/01/2025
Groundbreaking device sets new standard in the management of patients with an elevated risk of sudden cardiac arrest
Groundbreaking device sets new standard in the management of patients with an elevated risk of sudden cardiac arrest
Groundbreaking device sets new...
05/01/2025
EP Lab Digest
News
05/01/2025
Catheter Precision, Inc., a US-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced that new clinical data about VIVO is available.
Catheter Precision, Inc., a US-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced that new clinical data about VIVO is available.
Catheter Precision, Inc., a...
05/01/2025
EP Lab Digest
News
04/29/2025
Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025
Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025
Milestone results formed the...
04/29/2025
EP Lab Digest
News
04/29/2025
Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at the Heart Rhythm Society meeting.
Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at the Heart Rhythm Society meeting.
Huxley Medical unveiled...
04/29/2025
EP Lab Digest
News
04/29/2025
New data highlights strong wear compliance, meaningful arrhythmia detection, and continuity of care in community-based advanced practice provider-driven model
New data highlights strong wear compliance, meaningful arrhythmia detection, and continuity of care in community-based advanced practice provider-driven model
New data highlights strong wear...
04/29/2025
EP Lab Digest
News
04/28/2025
iRhythm Technologies, Inc. announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society’s annual meeting, HRS2025.
iRhythm Technologies, Inc. announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society’s annual meeting, HRS2025.
iRhythm Technologies, Inc....
04/28/2025
EP Lab Digest
News
04/27/2025
Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker
Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker
Late-breaking data from Abbott's...
04/27/2025
EP Lab Digest
News
04/26/2025
Medtronic plc, announced positive clinical outcomes from two studies in atrial fibrillation patients treated with the Affera™ family of technologies, including the next-generation Sphere-360™ single-shot pulsed field ablation catheter and the...
Medtronic plc, announced positive clinical outcomes from two studies in atrial fibrillation patients treated with the Affera™ family of technologies, including the next-generation Sphere-360™ single-shot pulsed field ablation catheter and the...
Medtronic plc, announced...
04/26/2025
EP Lab Digest
News
04/26/2025
Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA System. The 12-month results of the Volt CE Mark Study confirm the long-term safety...
Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA System. The 12-month results of the Volt CE Mark Study confirm the long-term safety...
Long-term data from the Volt CE...
04/26/2025
EP Lab Digest
News
04/25/2025
Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF...
Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF...
Kardium Inc., a private medical...
04/25/2025
EP Lab Digest